EMA Lapsed: Infanrix Penta (Diphtheria toxoid;tetanus toxoid;Bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin);poliovirus (inactivated) (type 1 (Mahoney strain), type 2 (MEF-1 strain), type 3 (Saukett strain));hepatitis B surface antigen) — GlaxoSmithKline Biologicals S.A.

View source ↗

Summary

EMA status indicates Infanrix Penta is lapsed, with the product no longer active in this market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Hepatitis B
• Immunization
• Polio
• Tetanus
• Whooping Cough

Drugs mentioned

• Infanrix Penta

Snippet

Status: Lapsed. Therapeutic area: Hepatitis B;Tetanus;Immunization;Whooping Cough;Poliomyelitis;Diphtheria. MAH: GlaxoSmithKline Biologicals S.A.. Decision date: 31/08/2010